BRÈVE

sur CROSSJECT (EPA:ALCJ)

Crossject: Information on the number of voting rights and shares

Graphique de l'évolution du cours de l'action CROSSJECT (EPA:ALCJ).

Crossject, a company specializing in the development of medicines for emergencies, has communicated the total number of voting rights and shares making up its share capital as of May 31, 2024.

As of May 31, 2024, the company's share capital consisted of 36,763,256 shares. The total number of theoretical voting rights attached to these shares was 45,014,346, while the number of exercisable voting rights was 44,883,574.

These figures take into account shares held by the company itself as well as those registered under its liquidity contract, which are deprived of voting rights. In total, 130,772 shares were deprived of voting rights.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de CROSSJECT